The largest database of trusted experimental protocols
> Chemicals & Drugs > Amino Acid > FGFR4 protein, human

FGFR4 protein, human

FGFR4 protein, a member of the fibroblast growth factor receptor family, plays a key role in regulating cell growth, differentiation, and survival.
It is involved in various biological processes, including embryonic development, tissue homeostasis, and disease pathogenesis.
The FGFR4 protein is a potential target for therapeutic interventions in conditions such as cancer, metabolic disorders, and genetic disorders.
Researchers can utilize PubCompare.ai's AI-driven platform to optimize their FGFR4 protein research protocols by easily locating and comparing procedures from literature, pre-prints, and patents, and identifying the best apppraches.
The intuitive tools and AI-powered analysis provided by PubCompare.ai can help streamline experiments and improve research outcomes.

Most cited protocols related to «FGFR4 protein, human»

Samples were fixed in either 10% neutral buffered formalin, dehydrated with ethanol and embedded in paraffin wax or fixed in 4% paraformaldehyde and embedded in OCT compound. Sections from paraffin (5 μm) and OCT (20 μm) blocks were processed using standard pre-treatment conditions for each per the RNAscope multiplex fluorescent reagent kit version 2 (Advanced Cell Diagnostics) assay protocol. TSA-plus fluorescein, Cy3 and Cy5 fluorophores were used at 1:500 dilution. Micrographs were acquired with a laser scanning confocal fluorescence microscope (Zeiss LSM780) and processed with ImageJ and Imaris (version 9.2.0, Oxford Instruments). smFISH experiments were performed on at least 2 human or mouse subjects distinct from the donors used for sequencing, and quantifications were based on at least 10 fields of view in each. For smFISH, fields of view were scored manually, calling a cell positive for each gene probed if its nucleus had >3 associated expression puncta. Proprietary (Advanced Cell Diagnostics) probes used were: KRT5 (547901-C2), SERPINB3 (828601-C3), SFTPC (452561-C2), WIF1 (429391), CLDN5 (517141-C2, 517141-C3), MYC (311761-C3), ACKR1 (525131, 525131-C2), COL1A2 (432721), GPC3 (418091-C2), SERPINF1 (564391-C3), C20rf85 (560841-C3), DHRS9 (467261), GJA5 (471431), CCL21 (474371-C2), COX4I2 (570351-C3), APOE (433091-C2), ACGT2 (828611-C2), ASPN (404481), IGSF21 (572181-C3), GPR34 (521021), EREG (313081), GPR183 (458801-C2), TREM2 (420491-C3), CHI3L1 (408121), MYRF (499261), AGER (470121-C3), TBX5 (564041), KCNK3 (536851), ACVRL1 (559221), SERPINA1 (435441), HHIP (464811), Slc7a10 (497081-C2), Fgfr4 (443511), Pi16 (451311-C2), Serpinf1 (310731), Hhip (448441-C3), Sftpc (314101-C2), Nkx2–1 (434721-C3), and Myrf (524061).
Publication 2020
ACVRL1 protein, human ApoE protein, human Biological Assay CCL21 protein, human Cell Nucleus Cells COL1A2 protein, human DARC protein, human Diagnosis Donors EREG protein, human Ethanol FGFR4 protein, human Fluorescein Fluorescence Formalin Genes GPC3 protein, human HHIP protein, human Homo sapiens KRT5 protein, human Microscopy, Confocal Mus NKX2-1 protein, human Paraffin paraform RAGE receptor protein, human SERPINA1 protein, human SERPINB3 protein, human Technique, Dilution TREM2 protein, human
Samples were fixed in either 10% neutral buffered formalin, dehydrated with ethanol and embedded in paraffin wax or fixed in 4% paraformaldehyde and embedded in OCT compound. Sections from paraffin (5 μm) and OCT (20 μm) blocks were processed using standard pre-treatment conditions for each per the RNAscope multiplex fluorescent reagent kit version 2 (Advanced Cell Diagnostics) assay protocol. TSA-plus fluorescein, Cy3 and Cy5 fluorophores were used at 1:500 dilution. Micrographs were acquired with a laser scanning confocal fluorescence microscope (Zeiss LSM780) and processed with ImageJ and Imaris (version 9.2.0, Oxford Instruments). smFISH experiments were performed on at least 2 human or mouse subjects distinct from the donors used for sequencing, and quantifications were based on at least 10 fields of view in each. For smFISH, fields of view were scored manually, calling a cell positive for each gene probed if its nucleus had >3 associated expression puncta. Proprietary (Advanced Cell Diagnostics) probes used were: KRT5 (547901-C2), SERPINB3 (828601-C3), SFTPC (452561-C2), WIF1 (429391), CLDN5 (517141-C2, 517141-C3), MYC (311761-C3), ACKR1 (525131, 525131-C2), COL1A2 (432721), GPC3 (418091-C2), SERPINF1 (564391-C3), C20rf85 (560841-C3), DHRS9 (467261), GJA5 (471431), CCL21 (474371-C2), COX4I2 (570351-C3), APOE (433091-C2), ACGT2 (828611-C2), ASPN (404481), IGSF21 (572181-C3), GPR34 (521021), EREG (313081), GPR183 (458801-C2), TREM2 (420491-C3), CHI3L1 (408121), MYRF (499261), AGER (470121-C3), TBX5 (564041), KCNK3 (536851), ACVRL1 (559221), SERPINA1 (435441), HHIP (464811), Slc7a10 (497081-C2), Fgfr4 (443511), Pi16 (451311-C2), Serpinf1 (310731), Hhip (448441-C3), Sftpc (314101-C2), Nkx2–1 (434721-C3), and Myrf (524061).
Publication 2020
ACVRL1 protein, human ApoE protein, human Biological Assay CCL21 protein, human Cell Nucleus Cells COL1A2 protein, human DARC protein, human Diagnosis Donors EREG protein, human Ethanol FGFR4 protein, human Fluorescein Fluorescence Formalin Genes GPC3 protein, human HHIP protein, human Homo sapiens KRT5 protein, human Microscopy, Confocal Mus NKX2-1 protein, human Paraffin paraform RAGE receptor protein, human SERPINA1 protein, human SERPINB3 protein, human Technique, Dilution TREM2 protein, human
The whole-body Fxr knockout (KO) mice (Fxr WB KO) were reported and are on a pure C57BL/6J genetic background.16 (link), 17 (link) The generation of tissue-specific Fxr KO mice on a mixed genetic background has been described previously using the loxP/Cre technology with specific disruption of the Nr1h4 gene in hepatocytes (Fxr Liv KO) or in enterocytes (Fxr Int KO).18 (link) Specifically, the Fxr Liv KO and Fxr Int KO mice were generated by crossbreeding Fxr floxed/floxed mice with albumin cre (+) or villin cre (+) mice. But these mice were on a mixed genetic background with variable basal expression of bile acid synthetic genes. So in the current study, the congenic Fxr Liv KO and Fxr Int KO mice in the C57BL/6J genetic background were produced. Shp KO mice and hepatocyte-specific Shp transgenic mice (Albumin promoter derived, Shp Tg) have been reported.19 (link), 20 (link) Fxr WB KO mice with hepatocyte-specific Shp over-expression (Fxr WB KO/Shp Tg) were generated via crossing Fxr WB KO mice with Shp Tg mice, with all three strains on the pure C57BL/6J genetic background. Fgfr4 KO mice on a mixed C57/129SvJ background were provided by Dr. Curtis Klaassen (University of Kansas Medical Center). Fgfr4/Shp double KO (Fgfr4/Shp DKO) mice were generated by cross breeding Fgfr4 KO and Shp KO mice. Egr1 KO mice on a C57BL/6 genetic background were obtained from Taconic (Hudson, NY). C57BL/6J mice bred in the same animal facility were used as wild-type (WT) controls for KO mice on C57BL/6J background. If KO mice were on a mixed genetic background (Fgfr4 KO and Fgfr4/Shp DKO), littermates were used as controls.
Publication 2012
Albumins Animals Bile Acids Disruptive Technology EGR1 protein, human Enterocytes FGFR4 protein, human Gene Expression Genes Genetic Background Hepatocyte Human Body Mice, Inbred C57BL Mice, Knockout Mice, Laboratory Mice, Transgenic NOS2A protein, human Strains Tissues villin

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2012
Anabolism BLOOD Feces FGFR4 protein, human Patients Phenotype Serum
In RNA-Seq analysis, the q value is an adjusted P value, taking into account the FDR. A P value of 0.05 indicates that 5% of all tests will be false positives. An FDR-adjusted P value of 0.05 implies that 5% of the tests found to be statistically significant (for example, by P value) will be false positives. Therefore, FDR has a greater power than P value, and we have mainly relied on FDR to gauge DEGs. To define DEGs, we used very stringent statistic threshold of ≥2 FC and FDR <0.05 to generate manageable lists in order for us to perform manual curation to classify each DEG in each cell type into non-redundant functional categories. Using the above statistical threshold, we identified a consensus of 853 DEGs upregulated in basal and 940 DEGs in luminal cells (Supplementary Data 1). Notably, to avoid the misunderstanding that genes not presented in the ‘stringent' lists are not DEGs, we also listed genes that passed a relatively loose but still statistically significant cutoff (that is, FC≥2 and P<0.05) in Supplementary Data 1. This latter cutoff resulted in more DEGs in basal (n=1,432) and luminal (n=1,548) cell populations (Supplementary Data 1). For example, FGFR3 (Fig. 3a) and some Pol I complex subunits (Fig. 4e; for example, POLR1B (P=0.006, FDR=0.069), POLR1C (P=0.006, FDR=0.069), NIP7 (P=0.005, FDR=0.060), and ESF1 (P=0.006, FDR=0.063) were not in the list with FDR<0.05, but were in the list with P<0.05. For Fig. 3a, the reason we chose FGFR3 (P=0.006, FDR=0.07) for demonstration was its abundance over other differentially expressed FGFRs (for example, the mean FPKM in basal cell, FGFR3=11 versus FGFR4=1), although its FDR was slightly above the stringent cutoff of 0.05. To get more reliable and manageable results, we mainly used the fewer DEGs lists for bioinformatics analysis.
For Fig. 1i, we identified the top 50 putative marker genes specific for each lineage inferred from transcriptomes based on both relative differential expression (FC) and absolute expression levels (normalized read counts). To increase the confidence of this selection, we scanned the genes from the stringent DEGs lists. Thus, the genes showing high-RNA expression (normalized read counts>300) in both cell types, regardless of the differential FC, would be excluded due to the high probability of protein expression in both cell types. Likewise, genes showing high FC difference between the two cell types but having minimal RNA expression in either cell type (that is, normalized read counts<300, indicating the less probability of robust protein expression) would also be eliminated. Note that normalized read counts of 300 (quite high) is an arbitrary set-up to increase the reliability of this selection. Using these criteria, we could identify >100 genes unique for each cell type, and the top 50 were shown in Fig. 1i. Notably, FGFR3 is not in the top 50, but we included it in Fig. 1i owing to the experimental data and for the reasons discussed above.
Full text: Click here
Publication 2016
Cells FGFR3 protein, human FGFR4 protein, human Fibroblast Growth Factor Receptors Genes Phenobarbital Population Group Proteins Protein Subunits RNA-Seq RNA Polymerase I Transcription, Genetic Transcriptome

Most recents protocols related to «FGFR4 protein, human»

To induce LVH, 8-week-old male mice were fed a high phosphorus diet, which contained modified AIN-93G, lactose 20.0%, sucrose 2.023%, β-corn starch 20.3486%, α-corn starch 7.0%, CaCO3 0.55%, Ca(H2PO4)2 5.05%, and phosphate 1.5g/100g (Oriental Yeast, Tokyo, Japan) 1 day after left heminephrectomy (removal of the whole left kidney). This diet was provided for the induction of FGF23 and was administered with a continuous subcutaneous dose of 100 mg/kg IS (I3875; Sigma-Aldrich, St. Louis, MO) or 28 μl/day of NS (Otsuka Pharmaceutical Factory, Tokushima, Japan) for 4 weeks using a micro-osmotic pump (2002-0000296; Alzet, Cupertino, CA). Half of the mice were treated with a continuous intraperitoneal dose of 7.5 mg/kg H3B-6527 (H3B), which is an FGFR4 inhibitor (S8675; Selleck Biotech, Tokyo, Japan), or 3.6 μl/day of NS using a micro-osmotic pump (1004-0009922; Alzet) for 4 weeks. The 2,002-pumps were replaced biweekly. To examine the effect of IS administration on cardiac hypertrophy and fibrosis, the mice were divided into the five following groups: sham; control; IS + NS; NS + H3B; and IS + H3B. Sham mice were treated with anesthesia, skin incision, and laparotomy, but did not have pumps inserted and were fed a normal phosphorus diet (CRF-1LID10; Oriental Yeast, Tokyo, Japan). The mice were operated on day 0, observed for 4 weeks, and euthanized on day 28. The mice were anesthetized intraperitoneally with medetomidine hydrochloride (0.3 mg/kg body weight; Wako, Osaka, Japan), midazolam (4 mg/kg body weight, Sandoz, Tokyo, Japan), and butorphanol tartrate (5 mg/kg body weight, Wako). The body temperature of the mice was maintained at 37°C during the whole procedure.
Full text: Click here
Publication 2023
Anesthesia Asian Persons Body Temperature Body Weight Butorphanol Tartrate Carbonate, Calcium Cardiac Hypertrophy Cornstarch Diet FGF23 protein, human FGFR4 protein, human Fibrosis H3B-6527 Heminephrectomy Lactose Laparotomy Males Medetomidine Hydrochloride Mice, House Midazolam Nephrectomy Osmosis Pharmaceutical Preparations Phosphates Phosphorus Skin Sucrose Yeast, Dried
To perform western blot analysis, H9c2 cells were harvested with cell lysis buffer (Mammalian Protein Extraction Reagent, 78501; Pierce Thermo Scientific, Tokyo, Japan) containing protease inhibitors (#04080-11; Nacalai Tesque Inc.) and phosphatase inhibitors (#07575-51; Nacalai Tesque Inc.) on ice for 15 min. The supernatants of protein lysates were collected after 10 min of centrifugation at 10,000 × g. The protein concentrations of cell lysates were determined using a bicinchoninic acid (BCA) protein assay kit (Thermo Fisher Scientific). The samples (5 μg) were separated on 5–20% sodium dodecyl sulfate-polyacrylamide gels (#2331830; Atto, Tokyo, Japan) and transferred onto polyvinylidene difluoride membranes (BioRad, Hercules, CA) using Trans-Blot Turbo (BioRad). After being blocked with Blocking One (#03953-95; Nacalai Tesque Inc.) for 30 min at room temperature, the membranes were washed in Tris-buffered saline containing 0.1% Tween 20 (polyoxyethylene sorbitan monolaurate, 35624-15; Nacalai Tesque Inc.) three times for 10 min and incubated with primary antibodies at 4°C overnight. The following antibodies were used as primary antibodies: monoclonal anti-rat FGF23 antibody (1:500, MAB2629; R&D Systems); polyclonal anti-goat FGF23 antibody (1:1000, ab123502; Abcam, Cambridge, UK); polyclonal anti-rabbit FGFR4 antibody (1:1000, ab119378; Abcam); polyclonal anti-rabbit FGFR4 (phospho Y642; pFGFR4) antibody (1:1000, ab192589; Abcam); polyclonal anti-rabbit furin antibody (1:1000, PA1-062; Thermo Fisher Scientific); polyclonal anti-rabbit hypoxia-inducible factor 1 alpha (HIF1α) antibody (1:1000, NB100-134; Novus Biologicals, Centennial, CO); polyclonal anti-rabbit polypeptide GALNT3 antibody (1:1000, SAB2106736; Sigma-Aldrich); and anti-rabbit α/β tubulin (1:1000, CST#2148; Cell Signaling Technology, Danvers, MA). After being washed in Tris-buffered saline containing 0.1% Tween 20 three times, the membranes were incubated with the following horseradish peroxidase-conjugated secondary antibodies: donkey anti-rabbit IgG antibody (1:5000, NA934; GE Healthcare, Bucks, UK) and goat anti-rat IgG antibody (1:10,000, NA935; GE Healthcare) for 1 h. The bands were detected by the enhanced chemiluminescent method (ECL prime; GE Healthcare or Chemi-Lumi One Ultra; Nacalai Tesque Inc.), captured using a chemiluminescence imaging system (AE-9300 Ez-capture MG; Atto), and analyzed with ImageJ Software (National Institutes of Health, Bethesda, MD).
Full text: Click here
Publication 2023
anti-IgG Antibodies Antibodies, Anti-Idiotypic bicinchoninic acid Biological Assay Biological Factors Buffers Centrifugation Chemiluminescence dodecyl sulfate Equus asinus FGF23 protein, human FGFR4 protein, human Furin Goat HIF1A protein, human Horseradish Peroxidase Immunoglobulins inhibitors Mammals Novus Phosphoric Monoester Hydrolases polyacrylamide gels Polypeptides Polysorbates polyvinylidene fluoride Protease Inhibitors Proteins Rabbits Saline Solution Sodium-20 Tissue, Membrane Tubulin Tween 20 Western Blot
FGFR2K domain constructs, corresponding to P458 to E768 and with the C491A mutation, were expressed with an N-terminal His6-tag to aid in protein purification. The C491A mutation of FGFR2K is referred to as wild type throughout the text. The “0Y” construct of FGFR2K was prepared by mutating all five phosphorylatable tyrosines in the protein (i.e., Y466F/Y586L/Y588P/Y656F/Y657F). Note that Y586L and Y588P mutations mimic native positions in the FGFR4 isoform. Kinases were expressed in Escherichia coli BL21(DE3) cells and induced with 0.1 mM IPTG overnight at 20 °C. Protein was purified using Ni-NTA resin and size exclusion chromatography. The N-terminal His6-tag was cleaved using TEV protease and phosphorylated states were removed using FastAP alkaline phosphatase (Thermo Scientific). Anion exchange chromatography was performed to ensure purification of the unphosphorylated state. For NMR experiments, protein was expressed in minimal media with 15NH4Cl, deuterated glucose, 99% D2O, and ILV precursors, as previously described (29 (link)).
Publication 2023
Alkaline Phosphatase Anions Cells Chromatography Escherichia coli FGFR4 protein, human Gel Chromatography Glucose his6 tag Isopropyl Thiogalactoside Mutation Phosphotransferases Protein Isoforms Proteins Resins, Plant Synapsin I TEV protease Tyrosine
Fifty-two crystal structures that correspond to each of the four FGFR isoforms were analyzed: 32 FGFR1, 9 FGFR2, 3 FGFR3, and 8 FGFR4. PDBs with unresolved A-loops were removed from the analysis, as the A-loop was found to be an important part of the classification. Of the 208 conserved residues among all FGFR isoforms of the kinase domain, 192 of these residues were used in the analysis since some regions were consistently not resolved in crystal structures (e.g., P-loop and kinase insert). Using the 192 residues, a distance matrix of all PDBs was calculated using the minimum residue distance (MRD). PCA was then used on MRD of the 52 high-resolution crystal structures and plotted according to the PC1 and PC2. The first two PCs accounted for 66% and 7% of the total variance. From there, PDBs were clustered by the PC1 and PC2 using DBSCAN clustering algorithm (59 ) using Scikit-learn (60 ).
To determine the distances that account for the variance between clusters, a t-score was calculated as shown in Eq. 4, where diji and siji represent the average distance pair and the standard deviation of the distance within the cluster, respectively. t-score = dij1 - dij2sij1 + sij2
The t-score was then scaled (scaled t-score) by the minimum of the distance pair ( dij ) to enhance the t-score of smaller distances. scaled  t-score = t-scoremin(dij)
All distance pairs with a scaled t-score greater than 3.5 Å in magnitude and a minimum distance less than 4.5 Å were extracted. This yielded 43 distances formed in the active state, and 45 distances formed in the autoinhibited state. Next, distance pairs were filtered to represent unique contacts formed in the active and autoinhibited states. The first filtering was performed to remove long-range distances by removing distances that have an average PDB distance greater than 5 Å. The next filtering removed distances shared in active and autoinhibited states by removing average distances between the clusters that varied by 1 Å or less. Last, distances were filtered based on the stability of the contact in MD simulation. The stability of active and autoinhibited contacts was determined by the MD simulations starting from 2PVF and the FGFR2K homology model of 3KY2, respectively. Distances were removed if the percent contact formed was less than 25%, where a contact is defined as formed if the minimum residue heavy atom distance is less than 4.5 Å. Active distances removed include L647-L665, L647-P666, R625-L665, and K658-D677. Autoinhibited distances removed include T660-L665, R664-S702, R630-T660, R664-E695, R573-N662, and R573-R664. This yielded 20 active contacts formed in the active state but disrupted in the autoinhibited state, and 22 autoinhibited contacts formed in the autoinhibited state but disrupted in the active state (SI Appendix, Table S2). These contacts represented ~0.5% of the total number of conserved residue pairs
Publication 2023
A-Loop FGFR1 protein, human FGFR2 protein, human FGFR3 protein, human FGFR4 protein, human Fibroblast Growth Factor Receptors Phosphotransferases Protein Isoforms Walker Motifs
Habituation to the tests was carried out 2 weeks before surgery. Behavioral assessments were performed 1 week and 24 h prior to surgery to set pre-operative values. Then, behavioral analyses were carried out at 3 days, 5 days, 1 week, and once a week over 6 weeks after surgery.

Open field: Animals were placed in a 50 × 50 cm square arena. Spontaneous motor activity was video-recorded over 10 min. The first two minutes were considered habituation time and were systematically excluded from analysis. Recordings were first performed on a smooth ground and then repeated on sandpaper surfaces with two types of granularities, i.e., 50 and 240 mean grain size/µm (adapted from [34 (link),35 (link)]). The following parameters were analyzed: time spent by zone (s), speed by zone (cm/s), and time of immobility (s) (defined as no movement for more than 2 s). Zones were set as follow: total arena, arena center, arena periphery for smooth surface and zone of granularity 50, zone of granularity 240 for sandpaper surface. Center region size was set as 20 × 20 cm, and the periphery corresponds to the remaining area. Zones of granularities 50 and 240 were designed as 25 × 25 cm square and placed in alternance. Ethotrack software (Innovation Net, Tiranges, France) was used for the automatized video tracking and analysis.

CatWalkTM: A dynamic walking pattern was analyzed using the CatWalk™ test (CatWalk XT™, Noldus, Wageningen, The Netherlands). Animals walked through a corridor on a backlighted glass plate. Paw placements were recorded by a camera placed under the glass plate. Six runs per sessions were recorded. Runs were analyzed only if the following criteria were met: average speed comprised between 5 and 30 cm/s, and combined to a maximum speed variation of 70% (adapted from [36 (link)]). Several parameters were analyzed, including base of support, print position, and max contact. Animals included in the experimental and control groups had similar weights and average motion speed, allowing for equivalent detection and comparison between groups, as previously described [36 (link)]. Additionally, we have quantified the percentage of detected ipsilateral hind paws prior traumatism and over the first week after SCI.

Number of mice included in the behavioral study: 18 C57BL6/6J underwent SCI and pHIV-Fgfr4 vector injections (12 females and 6 males, referred to as experimental mice); 19 mice underwent SCI and pHIV-mCherry vector injections (12 females and 7 males, referred to as control mice).
Full text: Click here
Publication 2023
Animals Cereals Cloning Vectors Females FGFR4 protein, human Males Mice, House Movement Operative Surgical Procedures

Top products related to «FGFR4 protein, human»

Sourced in Germany, United States, United Kingdom, Netherlands, Spain, Japan, Canada, France, China, Australia, Italy, Switzerland, Sweden, Belgium, Denmark, India, Jamaica, Singapore, Poland, Lithuania, Brazil, New Zealand, Austria, Hong Kong, Portugal, Romania, Cameroon, Norway
The RNeasy Mini Kit is a laboratory equipment designed for the purification of total RNA from a variety of sample types, including animal cells, tissues, and other biological materials. The kit utilizes a silica-based membrane technology to selectively bind and isolate RNA molecules, allowing for efficient extraction and recovery of high-quality RNA.
Sourced in United States, China, Japan, Germany, United Kingdom, Canada, France, Italy, Australia, Spain, Switzerland, Netherlands, Belgium, Lithuania, Denmark, Singapore, New Zealand, India, Brazil, Argentina, Sweden, Norway, Austria, Poland, Finland, Israel, Hong Kong, Cameroon, Sao Tome and Principe, Macao, Taiwan, Province of China, Thailand
TRIzol reagent is a monophasic solution of phenol, guanidine isothiocyanate, and other proprietary components designed for the isolation of total RNA, DNA, and proteins from a variety of biological samples. The reagent maintains the integrity of the RNA while disrupting cells and dissolving cell components.
Sourced in United States
FGFR4 is a recombinant protein that represents the extracellular domain of the human Fibroblast Growth Factor Receptor 4 (FGFR4). FGFR4 is a receptor tyrosine kinase involved in the regulation of cell growth and differentiation.
Sourced in United States, China, Germany, United Kingdom, Canada, Japan, France, Italy, Switzerland, Australia, Spain, Belgium, Denmark, Singapore, India, Netherlands, Sweden, New Zealand, Portugal, Poland, Israel, Lithuania, Hong Kong, Argentina, Ireland, Austria, Czechia, Cameroon, Taiwan, Province of China, Morocco
Lipofectamine 2000 is a cationic lipid-based transfection reagent designed for efficient and reliable delivery of nucleic acids, such as plasmid DNA and small interfering RNA (siRNA), into a wide range of eukaryotic cell types. It facilitates the formation of complexes between the nucleic acid and the lipid components, which can then be introduced into cells to enable gene expression or gene silencing studies.
Sourced in United States, United Kingdom, Germany, China, Canada, Japan, Macao, Italy, Sao Tome and Principe, Israel, Spain, Denmark, France, Finland, Australia, Morocco, Ireland, Czechia, Sweden, Uruguay, Switzerland, Netherlands, Senegal
β-actin is a protein that is found in all eukaryotic cells and is involved in the structure and function of the cytoskeleton. It is a key component of the actin filaments that make up the cytoskeleton and plays a critical role in cell motility, cell division, and other cellular processes.
Sourced in United States, Germany, United Kingdom, Canada, Switzerland, Japan, Spain, Italy, France, China, Brazil, Australia, Belgium, Jamaica, Czechia, Poland
TaqMan probes are a type of fluorescent DNA probe used in quantitative real-time PCR (qPCR) experiments. They consist of a sequence-specific oligonucleotide labeled with a fluorescent reporter dye and a quencher dye. During the qPCR process, the probe hybridizes to a target DNA sequence, allowing the reporter dye to emit a fluorescent signal that is proportional to the amount of target DNA present in the sample.
Sourced in United States, Germany, China, Japan, United Kingdom, Canada, France, Italy, Australia, Spain, Switzerland, Belgium, Denmark, Netherlands, India, Ireland, Lithuania, Singapore, Sweden, Norway, Austria, Brazil, Argentina, Hungary, Sao Tome and Principe, New Zealand, Hong Kong, Cameroon, Philippines
TRIzol is a monophasic solution of phenol and guanidine isothiocyanate that is used for the isolation of total RNA from various biological samples. It is a reagent designed to facilitate the disruption of cells and the subsequent isolation of RNA.
Sourced in United States
FGFR4 is a receptor tyrosine kinase that plays a role in fibroblast growth factor signaling. It is a member of the fibroblast growth factor receptor family.
Sourced in United States, Germany, United Kingdom, Japan, Lithuania, France, Italy, China, Spain, Canada, Switzerland, Poland, Australia, Belgium, Denmark, Sweden, Hungary, Austria, Ireland, Netherlands, Brazil, Macao, Israel, Singapore, Egypt, Morocco, Palestine, State of, Slovakia
The High-Capacity cDNA Reverse Transcription Kit is a laboratory tool used to convert RNA into complementary DNA (cDNA) molecules. It provides a reliable and efficient method for performing reverse transcription, a fundamental step in various molecular biology applications.
Sourced in United States, China, Germany, Japan, United Kingdom, France, Canada, Italy, Australia, Switzerland, Denmark, Spain, Singapore, Belgium, Lithuania, Israel, Sweden, Austria, Moldova, Republic of, Greece, Azerbaijan, Finland
Lipofectamine 3000 is a transfection reagent used for the efficient delivery of nucleic acids, such as plasmid DNA, siRNA, and mRNA, into a variety of mammalian cell types. It facilitates the entry of these molecules into the cells, enabling their expression or silencing.

More about "FGFR4 protein, human"

The FGFR4 protein, a member of the fibroblast growth factor receptor (FGFR) family, plays a crucial role in regulating cell growth, differentiation, and survival.
This receptor tyrosine kinase is involved in various biological processes, including embryonic development, tissue homeostasis, and disease pathogenesis.
The FGFR4 gene encodes the FGFR4 protein, which is a potential target for therapeutic interventions in conditions such as cancer, metabolic disorders, and genetic disorders.
Researchers can utilize PubCompare.ai's AI-driven platform to optimize their FGFR4 protein research protocols by easily locating and comparing procedures from literature, pre-prints, and patents, and identifying the best approaches.
The intuitive tools and AI-powered analysis provided by PubCompare.ai can help streamline experiments and improve research outcomes.
Techniques like the RNeasy Mini Kit, TRIzol reagent, and High-Capacity cDNA Reverse Transcription Kit can be used to isolate and analyze FGFR4 gene expression.
Transfection reagents like Lipofectamine 2000 and Lipofectamine 3000 can be used to modulate FGFR4 expression in cell lines.
Downstream analysis can be performed using TaqMan probes and β-actin as a housekeeping gene.
By leveraging the power of PubCompare.ai's platform and incorporating relevant techniques, researchers can optimize their FGFR4 protein studies and gain valuable insights into the role of this receptor in various biological processes and disease states.